Published 15 August 2024 To permit the use of milk fat globule membrane enriched whey protein concentrate as a nutritive substance in infant formula products. Approval A1307 Approval report (704KB) A1307 Supporting document at Approval (1.41MB) Call for submissions A1307 Call for submissions (447KB) A1307 Supporting document 1 - risk and technical assessment (8.42MB) A1307 Application - from the applicant (15.9MB) The submissions from the consultation have been published on the A1307 - Milk fat globule membrane as a nutritive substance in infant formula products page of the FSANZ Consultation Hub. Administrative Assessment A1307 Administrative assessment report (121KB) A1307 Executive summary - applicant (106KB) Page last updated: 22 July 2025